Lp(a): New Drugs Redefine Heart Health by 2028
One in five people have high Lp(a), a heart disease risk. New drugs arriving by 2028 offer 50-80% reductions, changing preventative cardiology.
One in five people have high Lp(a), a heart disease risk. New drugs arriving by 2028 offer 50-80% reductions, changing preventative cardiology.
ZN-207's setback challenges heart drug innovation. See how pharma is shifting to CRISPR and AI for future heart disease treatments.
Novartis halted its pelacarsen trial in 2025. Why did this promising Lp(a) drug fail, and what does it mean for future heart disease treatments?
70% of defense cyberattacks now use AI. Learn why this surge in AI-powered threats matters for global security and what's next for military tech.
Peace deals in 2026 unexpectedly cause 5% commodity price swings. Understand how geopolitical stability impacts oil, grains, and your investments.
Facing tight freight capacity? See why Q4 2025 saw 8% truckload rate hikes. Learn to diversify 30-40% long-haul to intermodal to cut costs and volatility.
Global Horizons Consulting shows how businesses can integrate real-time geopolitical risk into strategy to avoid disruption and find actionable intelligence
ANALYSIS: Decoding the News with Expert Analysis and Slightly Playful Insights The 24/7 news cycle often feels like drinking from a firehose, making it challenging…
Opinion: The digital economy isn’t just a trend for small businesses; it’s the only economy that matters anymore, and any enterprise resisting this fundamental shift…
Key Takeaways Nations like Denmark and Uruguay demonstrate that achieving over 90% renewable electricity generation is feasible through strategic investments in wind and hydro power,…